The SA B.1.351 variant was tested in humans against the mRNA-1273 Moderna vaccine. The variant led to a 6.4 fold decrease in neutralizing serum produced from the participants. The vaccine still effectively neutralized the variant despite a decrease in the concentration. There was no viral escape detected and the vaccine still met neutralizing titers set in NHP studies.